Michael Blum joins SeqOne Genomics to Head the Company's Research and Development
Copyright 2022, Business Wire.
news
2022-10-20 13:30:00

MONTPELLIER, France--(BUSINESS WIRE)--SeqOne Genomics, today announced that Michael Blum, Ph.D. is joining the company to lead its research and development department. He is tasked with driving SeqOne's R&D strategy notably in the area of rare diseases and oncology through the use of machine learning and data science. Michael started his career as a biostatistician and bioinformatician at the CNRS where he developed software solutions that enabled complex genomic data analysis for biologist
